A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma

NCT05074992 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Support withdrawn from drug company supplying IMP

Conditions

Glioblastoma

Interventions

DRUG: Ipilimumab

Sponsor

University College, London

Collaborators

[object Object]